ectomy or bypass
surgery who are not at high risk of bleeding should be
considered for aspirin (75 e 100 mg daily) and low dose
rivaroxaban (2.5 mg twice daily) to reduce the risk of
MACE and MALE. Those persons undergoing infrainguinal
bypass surgery with autogenous vein who are not at high
bleeding risk may be considered for treatment with
vitamin K antagonist to improve graft patency